FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Biochim Biophys Acta Gen Subj / A highly prevalent equine glycogen storage disease is explai...
Biochimica et biophysica acta. General subjects2016; 1861(1 Pt A); 3388-3398; doi: 10.1016/j.bbagen.2016.08.021

A highly prevalent equine glycogen storage disease is explained by constitutive activation of a mutant glycogen synthase.

Abstract: Equine type 1 polysaccharide storage myopathy (PSSM1) is associated with a missense mutation (R309H) in the glycogen synthase (GYS1) gene, enhanced glycogen synthase (GS) activity and excessive glycogen and amylopectate inclusions in muscle. Equine muscle biochemical and recombinant enzyme kinetic assays in vitro and homology modelling in silico, were used to investigate the hypothesis that higher GS activity in affected horse muscle is caused by higher GS expression, dysregulation, or constitutive activation via a conformational change. PSSM1-affected horse muscle had significantly higher glycogen content than control horse muscle despite no difference in GS expression. GS activity was significantly higher in muscle from homozygous mutants than from heterozygote and control horses, in the absence and presence of the allosteric regulator, glucose 6 phosphate (G6P). Muscle from homozygous mutant horses also had significantly increased GS phosphorylation at sites 2+2a and significantly higher AMPKα1 (an upstream kinase) expression than controls, likely reflecting a physiological attempt to reduce GS enzyme activity. Recombinant mutant GS was highly active with a considerably lower K for UDP-glucose, in the presence and absence of G6P, when compared to wild type GS, and despite its phosphorylation. Elevated activity of the mutant enzyme is associated with ineffective regulation via phosphorylation rendering it constitutively active. Modelling suggested that the mutation disrupts a salt bridge that normally stabilises the basal state, shifting the equilibrium to the enzyme's active state. This study explains the gain of function pathogenesis in this highly prevalent polyglucosan myopathy.
Copyright © 2016 Elsevier B.V. All rights reserved.
Get Full Text
Publication Date: 2016-08-31 PubMed ID: 27592162PubMed Central: PMC5148651DOI: 10.1016/j.bbagen.2016.08.021Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • N.I.H.
  • Extramural
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study explains the cause of a common glycogen storage disease in horses, known as type 1 polysaccharide storage myopathy (PSSM1), is due to the constitutive activation of a mutant glycogen synthase, an enzyme involved in the storage of glucose as glycogen.

About the Research Study

  • The research was aimed at understanding the underlying cause of equine type 1 polysaccharide storage myopathy (PSSM1), a common glycogen storage disease in horses. This condition is associated with a mutation in the glycogen synthase gene (GYS1), leading to excessive glycogen and a specific type of starch called amylopectin in muscles.
  • The researchers conducted a variety of experiments, including muscle biochemical assays, recombinant enzyme kinetic assays, and homology modeling, to test their hypothesis. The hypothesis was whether a higher activity of the glycogen synthase (GS) in the muscles of affected horses is caused by higher GS expression, dysregulation, or continuous activation due to a change in structure.

Findings of the Study

  • The study found that the muscles of PSSM1-affected horses had significantly higher glycogen content than the muscles of control horses. And this was despite no difference in GS expression, ruling out the hypothesis of enhanced GS expression being the cause.
  • A significant difference was also noted in GS activity between muscle samples of homozygous mutant horses (those with two copies of the mutation) and the control horses. The researchers observed this in both the presence and absence of the glucose 6 phosphate (G6P) regulator. This suggested that the increased GS activity results from constitutive activation due to a conformational change, rather than dysregulation.
  • A physiological attempt to reduce GS enzyme activity in homozygous mutant horses was evident by the significant increase in AMPKα1 (an upstream kinase) expression and GS phosphorylation at sites 2+2a in their muscles, when compared to controls.
  • Recombinant mutant GS, in comparison to wild type GS, showed elevated activity despite presence or absence of G6P or its phosphorylation, confirming the constitutive activation of the mutant enzyme.
  • Modeling results suggested that the mutation might be disrupting a salt bridge which normally stabilizes the enzyme’s basal state, propelling the equilibrium towards the enzyme’s active state. This finding provides an explanation for the gain of function pathogenesis in this highly prevalent glycogen storage disease.

Conclusion of the Study

  • The research concluded that constitutive activation of a mutant glycogen synthase due to a conformational change is the major cause of the higher glycogen content in the muscles of PSSM1-affected horses. Dysregulation or higher expression of GS were not found to be accountable. This research imparts crucial understanding towards the pathogenesis of this widely common equine glycogen storage disease.

Cite This Article

APA
Maile CA, Hingst JR, Mahalingan KK, O'Reilly AO, Cleasby ME, Mickelson JR, McCue ME, Anderson SM, Hurley TD, Wojtaszewski JFP, Piercy RJ. (2016). A highly prevalent equine glycogen storage disease is explained by constitutive activation of a mutant glycogen synthase. Biochim Biophys Acta Gen Subj, 1861(1 Pt A), 3388-3398. https://doi.org/10.1016/j.bbagen.2016.08.021

Publication

Biochimica et biophysica acta. General subjects
ISSN: 0304-4165
NlmUniqueID: 101731726
Country: Netherlands
Language: English
Volume: 1861
Issue: 1 Pt A
Pages: 3388-3398
PII: S0304-4165(16)30321-X

Researcher Affiliations

Maile, C A
  • Comparative Neuromuscular Diseases Laboratory, Department of Clinical Sciences and Services, Royal Veterinary College, London, UK.
Hingst, J R
  • Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Denmark.
Mahalingan, K K
  • Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, USA.
O'Reilly, A O
  • School of Natural Sciences and Psychology, Liverpool John Moores University, Liverpool, UK.
Cleasby, M E
  • Department of Comparative Biomedical Sciences, Royal Veterinary College, London, UK.
Mickelson, J R
  • Veterinary Biomedical Sciences Department, University of Minnesota, St. Paul, MN, USA.
McCue, M E
  • Veterinary Population Medicine Department, University of Minnesota, St. Paul, MN, USA.
Anderson, S M
  • Veterinary Population Medicine Department, University of Minnesota, St. Paul, MN, USA.
Hurley, T D
  • Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, USA.
Wojtaszewski, J F P
  • Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Denmark.
Piercy, R J
  • Comparative Neuromuscular Diseases Laboratory, Department of Clinical Sciences and Services, Royal Veterinary College, London, UK. Electronic address: rpiercy@rvc.ac.uk.

MeSH Terms

  • Adenylate Kinase / metabolism
  • Amino Acid Sequence
  • Animals
  • Blotting, Western
  • Breeding
  • Enzyme Activation
  • Glucose Transporter Type 4 / metabolism
  • Glucose-6-Phosphate / metabolism
  • Glycogen / metabolism
  • Glycogen Storage Disease / enzymology
  • Glycogen Storage Disease / epidemiology
  • Glycogen Synthase / chemistry
  • Glycogen Synthase / genetics
  • Glycogen Synthase / metabolism
  • Glycogen Synthase Kinase 3 beta / metabolism
  • Horses / metabolism
  • Kinetics
  • Models, Molecular
  • Muscle, Skeletal / enzymology
  • Mutant Proteins / metabolism
  • Mutation / genetics
  • Phosphorylation
  • Prevalence
  • Protein Subunits / metabolism
  • Structural Homology, Protein
  • Uridine Diphosphate Glucose / metabolism

Grant Funding

  • K08 AR055713 / NIAMS NIH HHS
  • R01 DK079887 / NIDDK NIH HHS

References

This article includes 56 references
  1. Wilson WA, Roach PJ, Montero M, Baroja-Fernández E, Muñoz FJ, Eydallin G, Viale AM, Pozueta-Romero J. Regulation of glycogen metabolism in yeast and bacteria.. FEMS Microbiol Rev 2010 Nov;34(6):952-85.
    pmc: PMC2927715pubmed: 20412306doi: 10.1111/j.1574-6976.2010.00220.xgoogle scholar: lookup
  2. Buschiazzo A, Ugalde JE, Guerin ME, Shepard W, Ugalde RA, Alzari PM. Crystal structure of glycogen synthase: homologous enzymes catalyze glycogen synthesis and degradation.. EMBO J 2004 Aug 18;23(16):3196-205.
    pmc: PMC514502pubmed: 15272305doi: 10.1038/sj.emboj.7600324google scholar: lookup
  3. Jensen J, Lai YC. Regulation of muscle glycogen synthase phosphorylation and kinetic properties by insulin, exercise, adrenaline and role in insulin resistance.. Arch Physiol Biochem 2009 Feb;115(1):13-21.
    pubmed: 19267278doi: 10.1080/13813450902778171google scholar: lookup
  4. Gregory BL, Shelton GD, Bali DS, Chen YT, Fyfe JC. Glycogen storage disease type IIIa in curly-coated retrievers.. J Vet Intern Med 2007 Jan-Feb;21(1):40-6.
    pubmed: 17338148doi: 10.1892/0891-6640(2007)21[40:gsdtii]2.0.co;2google scholar: lookup
  5. Lohi H, Young EJ, Fitzmaurice SN, Rusbridge C, Chan EM, Vervoort M, Turnbull J, Zhao XC, Ianzano L, Paterson AD, Sutter NB, Ostrander EA, André C, Shelton GD, Ackerley CA, Scherer SW, Minassian BA. Expanded repeat in canine epilepsy.. Science 2005 Jan 7;307(5706):81.
    pubmed: 15637270doi: 10.1126/science.1102832google scholar: lookup
  6. Ozen H. Glycogen storage diseases: new perspectives.. World J Gastroenterol 2007 May 14;13(18):2541-53.
    pmc: PMC4146814pubmed: 17552001doi: 10.3748/wjg.v13.i18.2541google scholar: lookup
  7. Fyfe JC, Giger U, Van Winkle TJ, Haskins ME, Steinberg SA, Wang P, Patterson DF. Glycogen storage disease type IV: inherited deficiency of branching enzyme activity in cats.. Pediatr Res 1992 Dec;32(6):719-25.
    pubmed: 1337588doi: 10.1203/00006450-199212000-00020google scholar: lookup
  8. McCue ME, Valberg SJ, Miller MB, Wade C, DiMauro S, Akman HO, Mickelson JR. Glycogen synthase (GYS1) mutation causes a novel skeletal muscle glycogenosis.. Genomics 2008 May;91(5):458-66.
    pmc: PMC2430182pubmed: 18358695doi: 10.1016/j.ygeno.2008.01.011google scholar: lookup
  9. Valberg SJ, Cardinet GH 3rd, Carlson GP, DiMauro S. Polysaccharide storage myopathy associated with recurrent exertional rhabdomyolysis in horses.. Neuromuscul Disord 1992;2(5-6):351-9.
    pubmed: 1284408doi: 10.1016/s0960-8966(06)80006-4google scholar: lookup
  10. Naylor RJ, Livesey L, Schumacher J, Henke N, Massey C, Brock KV, Fernandez-Fuente M, Piercy RJ. Allele copy number and underlying pathology are associated with subclinical severity in equine type 1 polysaccharide storage myopathy (PSSM1).. PLoS One 2012;7(7):e42317.
    pmc: PMC3409190pubmed: 22860112doi: 10.1371/journal.pone.0042317google scholar: lookup
  11. Naylor RJ, Luis-Fuentes V, Livesey L, Mobley CB, Henke N, Brock K, Fernandez-Fuente M, Piercy RJ. Evaluation of cardiac phenotype in horses with type 1 polysaccharide storage myopathy.. J Vet Intern Med 2012 Nov-Dec;26(6):1464-9.
    pubmed: 22978303doi: 10.1111/j.1939-1676.2012.00988.xgoogle scholar: lookup
  12. Stanley RL, McCue ME, Valberg SJ, Mickelson JR, Mayhew IG, McGowan C, Hahn CN, Patterson-Kane JC, Piercy RJ. A glycogen synthase 1 mutation associated with equine polysaccharide storage myopathy and exertional rhabdomyolysis occurs in a variety of UK breeds.. Equine Vet J 2009 Jul;41(6):597-601.
    pubmed: 19803057doi: 10.2746/042516409x407611google scholar: lookup
  13. Herszberg B, McCue ME, Larcher T, Mata X, Vaiman A, Chaffaux S, Chérel Y, Valberg SJ, Mickelson JR, Guérin G. A GYS1 gene mutation is highly associated with polysaccharide storage myopathy in Cob Normand draught horses.. Anim Genet 2009 Feb;40(1):94-6.
    pubmed: 18822097doi: 10.1111/j.1365-2052.2008.01778.xgoogle scholar: lookup
  14. Schwarz B, Ertl R, Zimmer S, Netzmann Y, Klein D, Schwendenwein I, Hoven RV. Estimated prevalence of the GYS-1 mutation in healthy Austrian Haflingers.. Vet Rec 2011 Nov 26;169(22):583.
    pubmed: 21949056doi: 10.1136/vr.d5438google scholar: lookup
  15. Johlig L, Valberg SJ, Mickelson JR, Klukowska J, Reusser HR, Straub R, Gerber V. Epidemiological and genetic study of exertional rhabdomyolysis in a Warmblood horse family in Switzerland.. Equine Vet J 2011 Mar;43(2):240-5.
    pubmed: 21592222doi: 10.1111/j.2042-3306.2010.00161.xgoogle scholar: lookup
  16. McCoy AM, Schaefer R, Petersen JL, Morrell PL, Slamka MA, Mickelson JR, Valberg SJ, McCue ME. Evidence of positive selection for a glycogen synthase (GYS1) mutation in domestic horse populations.. J Hered 2014 Mar-Apr;105(2):163-72.
    pmc: PMC3920812pubmed: 24215078doi: 10.1093/jhered/est075google scholar: lookup
  17. Pederson BA, Csitkovits AG, Simon R, Schroeder JM, Wang W, Skurat AV, Roach PJ. Overexpression of glycogen synthase in mouse muscle results in less branched glycogen.. Biochem Biophys Res Commun 2003 Jun 13;305(4):826-30.
    pubmed: 12767905doi: 10.1016/s0006-291x(03)00862-3google scholar: lookup
  18. Valberg SJ, Ward TL, Rush B, Kinde H, Hiraragi H, Nahey D, Fyfe J, Mickelson JR. Glycogen branching enzyme deficiency in quarter horse foals.. J Vet Intern Med 2001 Nov-Dec;15(6):572-80.
    pubmed: 11817063doi: 10.1892/0891-6640(2001)015<0572:gbediq>2.3.co;2google scholar: lookup
  19. Raben N, Danon M, Lu N, Lee E, Shliselfeld L, Skurat AV, Roach PJ, Lawrence JC Jr, Musumeci O, Shanske S, DiMauro S, Plotz P. Surprises of genetic engineering: a possible model of polyglucosan body disease.. Neurology 2001 Jun 26;56(12):1739-45.
    pubmed: 11425943doi: 10.1212/wnl.56.12.1739google scholar: lookup
  20. Anderson C, Tatchell K. Hyperactive glycogen synthase mutants of Saccharomyces cerevisiae suppress the glc7-1 protein phosphatase mutant.. J Bacteriol 2001 Feb;183(3):821-9.
    pmc: PMC94947pubmed: 11208778doi: 10.1128/JB.183.3.821-829.2001google scholar: lookup
  21. Prats C, Cadefau JA, Cussó R, Qvortrup K, Nielsen JN, Wojtaszewski JF, Hardie DG, Stewart G, Hansen BF, Ploug T. Phosphorylation-dependent translocation of glycogen synthase to a novel structure during glycogen resynthesis.. J Biol Chem 2005 Jun 17;280(24):23165-72.
    pubmed: 15840572doi: 10.1074/jbc.M502713200google scholar: lookup
  22. Roach PJ. Glycogen and its metabolism.. Curr Mol Med 2002 Mar;2(2):101-20.
    pubmed: 11949930doi: 10.2174/1566524024605761google scholar: lookup
  23. Skurat AV, Wang Y, Roach PJ. Rabbit skeletal muscle glycogen synthase expressed in COS cells. Identification of regulatory phosphorylation sites.. J Biol Chem 1994 Oct 14;269(41):25534-42.
    pubmed: 7929255
  24. Roach PJ. Control of glycogen synthase by hierarchal protein phosphorylation.. FASEB J 1990 Sep;4(12):2961-8.
    pubmed: 2168324
  25. Bouskila M, Hunter RW, Ibrahim AF, Delattre L, Peggie M, van Diepen JA, Voshol PJ, Jensen J, Sakamoto K. Allosteric regulation of glycogen synthase controls glycogen synthesis in muscle.. Cell Metab 2010 Nov 3;12(5):456-66.
    pubmed: 21035757doi: 10.1016/j.cmet.2010.10.006google scholar: lookup
  26. Baskaran S, Roach PJ, DePaoli-Roach AA, Hurley TD. Structural basis for glucose-6-phosphate activation of glycogen synthase.. Proc Natl Acad Sci U S A 2010 Oct 12;107(41):17563-8.
    pmc: PMC2955087pubmed: 20876143doi: 10.1073/pnas.1006340107google scholar: lookup
  27. Zeqiraj E, Tang X, Hunter RW, García-Rocha M, Judd A, Deak M, von Wilamowitz-Moellendorff A, Kurinov I, Guinovart JJ, Tyers M, Sakamoto K, Sicheri F. Structural basis for the recruitment of glycogen synthase by glycogenin.. Proc Natl Acad Sci U S A 2014 Jul 15;111(28):E2831-40.
    pmc: PMC4104858pubmed: 24982189doi: 10.1073/pnas.1402926111google scholar: lookup
  28. Landau M, Mayrose I, Rosenberg Y, Glaser F, Martz E, Pupko T, Ben-Tal N. ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures.. Nucleic Acids Res 2005 Jul 1;33(Web Server issue):W299-302.
    pmc: PMC1160131pubmed: 15980475doi: 10.1093/nar/gki370google scholar: lookup
  29. Pederson BA, Cheng C, Wilson WA, Roach PJ. Regulation of glycogen synthase. Identification of residues involved in regulation by the allosteric ligand glucose-6-P and by phosphorylation.. J Biol Chem 2000 Sep 8;275(36):27753-61.
    pubmed: 10874034doi: 10.1074/jbc.M003342200google scholar: lookup
  30. Furukawa K, Tagaya M, Tanizawa K, Fukui T. Identification of Lys277 at the active site of Escherichia coli glycogen synthase. Application of affinity labeling combined with site-directed mutagenesis.. J Biol Chem 1994 Jan 14;269(2):868-71.
    pubmed: 8288640
  31. Baskaran S, Chikwana VM, Contreras CJ, Davis KD, Wilson WA, DePaoli-Roach AA, Roach PJ, Hurley TD. Multiple glycogen-binding sites in eukaryotic glycogen synthase are required for high catalytic efficiency toward glycogen.. J Biol Chem 2011 Sep 30;286(39):33999-4006.
    pmc: PMC3190777pubmed: 21835915doi: 10.1074/jbc.M111.264531google scholar: lookup
  32. Suzuki Y, Lanner C, Kim JH, Vilardo PG, Zhang H, Yang J, Cooper LD, Steele M, Kennedy A, Bock CB, Scrimgeour A, Lawrence JC Jr, DePaoli-Roach AA. Insulin control of glycogen metabolism in knockout mice lacking the muscle-specific protein phosphatase PP1G/RGL.. Mol Cell Biol 2001 Apr;21(8):2683-94.
    pmc: PMC86899pubmed: 11283248doi: 10.1128/MCB.21.8.2683-2694.2001google scholar: lookup
  33. Hedberg-Oldfors C, Oldfors A. Polyglucosan storage myopathies.. Mol Aspects Med 2015 Dec;46:85-100.
    pubmed: 26278982doi: 10.1016/j.mam.2015.08.006google scholar: lookup
  34. Chan TM, Exton JH. A rapid method for the determination of glycogen content and radioactivity in small quantities of tissue or isolated hepatocytes.. Anal Biochem 1976 Mar;71(1):96-105.
    pubmed: 1275237doi: 10.1016/0003-2697(76)90014-2google scholar: lookup
  35. Prats C, Helge JW, Nordby P, Qvortrup K, Ploug T, Dela F, Wojtaszewski JF. Dual regulation of muscle glycogen synthase during exercise by activation and compartmentalization.. J Biol Chem 2009 Jun 5;284(23):15692-700.
    pmc: PMC2708866pubmed: 19339242doi: 10.1074/jbc.M900845200google scholar: lookup
  36. Jensen J, Jebens E, Brennesvik EO, Ruzzin J, Soos MA, Engebretsen EM, O'Rahilly S, Whitehead JP. Muscle glycogen inharmoniously regulates glycogen synthase activity, glucose uptake, and proximal insulin signaling.. Am J Physiol Endocrinol Metab 2006 Jan;290(1):E154-E162.
    pubmed: 16118249doi: 10.1152/ajpendo.00330.2005google scholar: lookup
  37. Jensen J, Ruzzin J, Jebens E, Brennesvik EO, Knardahl S. Improved insulin-stimulated glucose uptake and glycogen synthase activation in rat skeletal muscles after adrenaline infusion: role of glycogen content and PKB phosphorylation.. Acta Physiol Scand 2005 Jun;184(2):121-30.
    pubmed: 15916672doi: 10.1111/j.1365-201X.2005.01437.xgoogle scholar: lookup
  38. Højlund K, Staehr P, Hansen BF, Green KA, Hardie DG, Richter EA, Beck-Nielsen H, Wojtaszewski JF. Increased phosphorylation of skeletal muscle glycogen synthase at NH2-terminal sites during physiological hyperinsulinemia in type 2 diabetes.. Diabetes 2003 Jun;52(6):1393-402.
    pubmed: 12765949doi: 10.2337/diabetes.52.6.1393google scholar: lookup
  39. Woods A, Salt I, Scott J, Hardie DG, Carling D. The alpha1 and alpha2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro.. FEBS Lett 1996 Nov 18;397(2-3):347-51.
    pubmed: 8955377doi: 10.1016/s0014-5793(96)01209-4google scholar: lookup
  40. Durante PE, Mustard KJ, Park SH, Winder WW, Hardie DG. Effects of endurance training on activity and expression of AMP-activated protein kinase isoforms in rat muscles.. Am J Physiol Endocrinol Metab 2002 Jul;283(1):E178-86.
    pubmed: 12067859doi: 10.1152/ajpendo.00404.2001google scholar: lookup
  41. Højlund K, Mustard KJ, Staehr P, Hardie DG, Beck-Nielsen H, Richter EA, Wojtaszewski JF. AMPK activity and isoform protein expression are similar in muscle of obese subjects with and without type 2 diabetes.. Am J Physiol Endocrinol Metab 2004 Feb;286(2):E239-44.
    pubmed: 14532170doi: 10.1152/ajpendo.00326.2003google scholar: lookup
  42. Zhang W, DePaoli-Roach AA, Roach PJ. Mechanisms of multisite phosphorylation and inactivation of rabbit muscle glycogen synthase.. Arch Biochem Biophys 1993 Jul;304(1):219-25.
    pubmed: 8391782doi: 10.1006/abbi.1993.1342google scholar: lookup
  43. Thomas JA, Schlender KK, Larner J. A rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose.. Anal Biochem 1968 Oct 24;25(1):486-99.
    pubmed: 5704765doi: 10.1016/0003-2697(68)90127-9google scholar: lookup
  44. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, Thompson JD, Higgins DG. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega.. Mol Syst Biol 2011 Oct 11;7:539.
    pmc: PMC3261699pubmed: 21988835doi: 10.1038/msb.2011.75google scholar: lookup
  45. Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen MY, Pieper U, Sali A. Comparative protein structure modeling using MODELLER.. Curr Protoc Protein Sci 2007 Nov;Chapter 2:Unit 2.9.
    pubmed: 18429317doi: 10.1002/0471140864.ps0209s50google scholar: lookup
  46. Willard L, Ranjan A, Zhang H, Monzavi H, Boyko RF, Sykes BD, Wishart DS. VADAR: a web server for quantitative evaluation of protein structure quality.. Nucleic Acids Res 2003 Jul 1;31(13):3316-9.
    pmc: PMC168972pubmed: 12824316doi: 10.1093/nar/gkg565google scholar: lookup
  47. Guex N, Diemand A, Peitsch MC. Protein modelling for all.. Trends Biochem Sci 1999 Sep;24(9):364-7.
    pubmed: 10470037doi: 10.1016/s0968-0004(99)01427-9google scholar: lookup
  48. Khanna M, Imasaki T, Chikwana VM, Perez-Miller S, Hunter GO, Mosley A, Takagi Y, Hurley TD. Expression and purification of functional human glycogen synthase-1 (hGYS1) in insect cells.. Protein Expr Purif 2013 Aug;90(2):78-83.
    pmc: PMC3720772pubmed: 23711380doi: 10.1016/j.pep.2013.05.007google scholar: lookup
  49. Annandale EJ, Valberg SJ, Mickelson JR, Seaquist ER. Insulin sensitivity and skeletal muscle glucose transport in horses with equine polysaccharide storage myopathy.. Neuromuscul Disord 2004 Oct;14(10):666-74.
    pubmed: 15351424doi: 10.1016/j.nmd.2004.05.007google scholar: lookup
  50. Højlund K, Birk JB, Klein DK, Levin K, Rose AJ, Hansen BF, Nielsen JN, Beck-Nielsen H, Wojtaszewski JF. Dysregulation of glycogen synthase COOH- and NH2-terminal phosphorylation by insulin in obesity and type 2 diabetes mellitus.. J Clin Endocrinol Metab 2009 Nov;94(11):4547-56.
    pubmed: 19837931doi: 10.1210/jc.2009-0897google scholar: lookup
  51. Jørgensen SB, Nielsen JN, Birk JB, Olsen GS, Viollet B, Andreelli F, Schjerling P, Vaulont S, Hardie DG, Hansen BF, Richter EA, Wojtaszewski JF. The alpha2-5'AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading.. Diabetes 2004 Dec;53(12):3074-81.
    pubmed: 15561936doi: 10.2337/diabetes.53.12.3074google scholar: lookup
  52. Wojtaszewski JF, Jørgensen SB, Hellsten Y, Hardie DG, Richter EA. Glycogen-dependent effects of 5-aminoimidazole-4-carboxamide (AICA)-riboside on AMP-activated protein kinase and glycogen synthase activities in rat skeletal muscle.. Diabetes 2002 Feb;51(2):284-92.
    pubmed: 11812734doi: 10.2337/diabetes.51.2.284google scholar: lookup
  53. Lai YC, Stuenaes JT, Kuo CH, Jensen J. Glycogen content and contraction regulate glycogen synthase phosphorylation and affinity for UDP-glucose in rat skeletal muscles.. Am J Physiol Endocrinol Metab 2007 Dec;293(6):E1622-9.
    pubmed: 17878227doi: 10.1152/ajpendo.00113.2007google scholar: lookup
  54. Ros S, García-Rocha M, Domínguez J, Ferrer JC, Guinovart JJ. Control of liver glycogen synthase activity and intracellular distribution by phosphorylation.. J Biol Chem 2009 Mar 6;284(10):6370-8.
    pubmed: 19124463doi: 10.1074/jbc.M808576200google scholar: lookup
  55. Nielsen JN, Wojtaszewski JF. Regulation of glycogen synthase activity and phosphorylation by exercise.. Proc Nutr Soc 2004 May;63(2):233-7.
    pubmed: 15294036doi: 10.1079/PNS2004348google scholar: lookup
  56. Costa GL, Bauer JC, McGowan B, Angert M, Weiner MP. Site-directed mutagenesis using a rapid PCR-based method.. Methods Mol Biol 1996;57:239-48.
    pubmed: 8850010doi: 10.1385/0-89603-332-5:239google scholar: lookup

Citations

This article has been cited 8 times.
  1. Laforêt P, Oldfors A, Malfatti E, Vissing J. 251st ENMC international workshop: Polyglucosan storage myopathies 13-15 December 2019, Hoofddorp, the Netherlands. Neuromuscul Disord 2021 May;31(5):466-477.
    doi: 10.1016/j.nmd.2021.01.010pubmed: 33602551google scholar: lookup
  2. Ying S, Zhihua Z, Yucan Z, Yu J, Qian L, Bixia Z, Weixia C, Zhifeng L. Molecular Diagnosis of Panel-Based Next-Generation Sequencing Approach and Clinical Symptoms in Patients With Glycogen Storage Disease: A Single Center Retrospective Study. Front Pediatr 2020;8:600446.
    doi: 10.3389/fped.2020.600446pubmed: 33344388google scholar: lookup
  3. Tarnopolsky MA. Myopathies Related to Glycogen Metabolism Disorders. Neurotherapeutics 2018 Oct;15(4):915-927.
    doi: 10.1007/s13311-018-00684-2pubmed: 30397902google scholar: lookup
  4. Williams ZJ, Bertels M, Valberg SJ. Muscle glycogen concentrations and response to diet and exercise regimes in Warmblood horses with type 2 Polysaccharide Storage Myopathy. PLoS One 2018;13(9):e0203467.
    doi: 10.1371/journal.pone.0203467pubmed: 30183782google scholar: lookup
  5. Tosi I, Art T, Cassart D, Farnir F, Ceusters J, Serteyn D, Lemieux H, Votion DM. Altered mitochondrial oxidative phosphorylation capacity in horses suffering from polysaccharide storage myopathy. J Bioenerg Biomembr 2018 Oct;50(5):379-390.
    doi: 10.1007/s10863-018-9768-6pubmed: 30143916google scholar: lookup
  6. Hansen S, Hopster-Iversen C, Berg L, Fjeldborg J, Massey C, Piercy RJ, Carstensen H. Chronic idiopathic myopathy in Icelandic horses: A case series. Equine Vet J 2025 Sep;57(5):1341-1346.
    doi: 10.1111/evj.14519pubmed: 40275651google scholar: lookup
  7. Lindsay-McGee V, Massey C, Li YT, Clark EL, Psifidi A, Piercy RJ. Characterisation of phenotypic patterns in equine exercise-associated myopathies. Equine Vet J 2025 Mar;57(2):347-361.
    doi: 10.1111/evj.14128pubmed: 38965932google scholar: lookup
  8. Mitra S, Chen B, Shelton JM, Nitschke S, Wu J, Covington L, Dear M, Lynn T, Verma M, Nitschke F, Fuseya Y, Iwai K, Evers BM, Minassian BA. Myofiber-type-dependent 'boulder' or 'multitudinous pebble' formations across distinct amylopectinoses. Acta Neuropathol 2024 Feb 27;147(1):46.
    doi: 10.1007/s00401-024-02698-xpubmed: 38411740google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.